399 related articles for article (PubMed ID: 28711506)
1. Sodium selenate activated Wnt/β-catenin signaling and repressed amyloid-β formation in a triple transgenic mouse model of Alzheimer's disease.
Jin N; Zhu H; Liang X; Huang W; Xie Q; Xiao P; Ni J; Liu Q
Exp Neurol; 2017 Nov; 297():36-49. PubMed ID: 28711506
[TBL] [Abstract][Full Text] [Related]
2. Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models.
van Eersel J; Ke YD; Liu X; Delerue F; Kril JJ; Götz J; Ittner LM
Proc Natl Acad Sci U S A; 2010 Aug; 107(31):13888-93. PubMed ID: 20643941
[TBL] [Abstract][Full Text] [Related]
3. The Role of Fluoxetine in Activating Wnt/β-Catenin Signaling and Repressing β-Amyloid Production in an Alzheimer Mouse Model.
Huang M; Liang Y; Chen H; Xu B; Chai C; Xing P
Front Aging Neurosci; 2018; 10():164. PubMed ID: 29910725
[TBL] [Abstract][Full Text] [Related]
4. Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice.
Tapia-Rojas C; Inestrosa NC
J Neurochem; 2018 Feb; 144(4):443-465. PubMed ID: 29240990
[TBL] [Abstract][Full Text] [Related]
5. Alteration of the Wnt/GSK3β/β‑catenin signalling pathway by rapamycin ameliorates pathology in an Alzheimer's disease model.
Chen J; Long Z; Li Y; Luo M; Luo S; He G
Int J Mol Med; 2019 Jul; 44(1):313-323. PubMed ID: 31115485
[TBL] [Abstract][Full Text] [Related]
6. Reversal of memory and neuropsychiatric symptoms and reduced tau pathology by selenium in 3xTg-AD mice.
Van der Jeugd A; Parra-Damas A; Baeta-Corral R; Soto-Faguás CM; Ahmed T; LaFerla FM; Giménez-Llort L; D'Hooge R; Saura CA
Sci Rep; 2018 Apr; 8(1):6431. PubMed ID: 29691439
[TBL] [Abstract][Full Text] [Related]
7. Selenomethionine promoted hippocampal neurogenesis via the PI3K-Akt-GSK3β-Wnt pathway in a mouse model of Alzheimer's disease.
Zheng R; Zhang ZH; Chen C; Chen Y; Jia SZ; Liu Q; Ni JZ; Song GL
Biochem Biophys Res Commun; 2017 Mar; 485(1):6-15. PubMed ID: 28109879
[TBL] [Abstract][Full Text] [Related]
8. Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):853-866. PubMed ID: 28981597
[TBL] [Abstract][Full Text] [Related]
9. Comparative Serum Proteomic Analysis of the Effects of Sodium Selenate on a Mouse Model of Alzheimer's Disease.
Chen P; Wang LX; Sui XJ; Li SM; Wang Y; Liu Q; Ni JZ
Biol Trace Elem Res; 2019 Dec; 192(2):263-276. PubMed ID: 30790121
[TBL] [Abstract][Full Text] [Related]
10. Osthole promotes neuronal differentiation and inhibits apoptosis via Wnt/β-catenin signaling in an Alzheimer's disease model.
Yao Y; Gao Z; Liang W; Kong L; Jiao Y; Li S; Tao Z; Yan Y; Yang J
Toxicol Appl Pharmacol; 2015 Dec; 289(3):474-81. PubMed ID: 26525509
[TBL] [Abstract][Full Text] [Related]
11. Huperzine A activates Wnt/β-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model.
Wang CY; Zheng W; Wang T; Xie JW; Wang SL; Zhao BL; Teng WP; Wang ZY
Neuropsychopharmacology; 2011 Apr; 36(5):1073-89. PubMed ID: 21289607
[TBL] [Abstract][Full Text] [Related]
12. Phosphoproteomic profiling of selenate-treated Alzheimer's disease model cells.
Chen P; Wang L; Wang Y; Li S; Shen L; Liu Q; Ni J
PLoS One; 2014; 9(12):e113307. PubMed ID: 25485856
[TBL] [Abstract][Full Text] [Related]
13. Silencing of aquaporin1 activates the Wnt signaling pathway to improve cognitive function in a mouse model of Alzheimer's disease.
Yu B; Zhang J; Li H; Sun X
Gene; 2020 Sep; 755():144904. PubMed ID: 32540373
[TBL] [Abstract][Full Text] [Related]
14. Toluidine blue O modifies hippocampal amyloid pathology in a transgenic mouse model of Alzheimer's disease.
Yuksel M; Biberoglu K; Onder S; Akbulut KG; Tacal O
Biochimie; 2018 Mar; 146():105-112. PubMed ID: 29248542
[TBL] [Abstract][Full Text] [Related]
15. LncRNA Rpph1 protects amyloid-β induced neuronal injury in SK-N-SH cells via miR-122/Wnt1 axis.
Gu R; Wang L; Tang M; Li SR; Liu R; Hu X
Int J Neurosci; 2020 May; 130(5):443-453. PubMed ID: 31718352
[No Abstract] [Full Text] [Related]
16. Neuroprotective Potential of Novel Multi-Targeted Isoalloxazine Derivatives in Rodent Models of Alzheimer's Disease Through Activation of Canonical Wnt/β-Catenin Signalling Pathway.
Machhi J; Sinha A; Patel P; Kanhed AM; Upadhyay P; Tripathi A; Parikh ZS; Chruvattil R; Pillai PP; Gupta S; Patel K; Giridhar R; Yadav MR
Neurotox Res; 2016 May; 29(4):495-513. PubMed ID: 26797524
[TBL] [Abstract][Full Text] [Related]
17. Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms.
Giuliani D; Ottani A; Zaffe D; Galantucci M; Strinati F; Lodi R; Guarini S
Neurobiol Learn Mem; 2013 Sep; 104():82-91. PubMed ID: 23726868
[TBL] [Abstract][Full Text] [Related]
18. Dickkopf 3 (Dkk3) Improves Amyloid-β Pathology, Cognitive Dysfunction, and Cerebral Glucose Metabolism in a Transgenic Mouse Model of Alzheimer's Disease.
Zhang L; Sun C; Jin Y; Gao K; Shi X; Qiu W; Ma C; Zhang L
J Alzheimers Dis; 2017; 60(2):733-746. PubMed ID: 28922151
[TBL] [Abstract][Full Text] [Related]
19. Wnt signaling in Alzheimer's disease: up or down, that is the question.
Boonen RA; van Tijn P; Zivkovic D
Ageing Res Rev; 2009 Apr; 8(2):71-82. PubMed ID: 19101658
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase 5 inhibitor mirodenafil ameliorates Alzheimer-like pathology and symptoms by multimodal actions.
Kang BW; Kim F; Cho JY; Kim S; Rhee J; Choung JJ
Alzheimers Res Ther; 2022 Jul; 14(1):92. PubMed ID: 35804462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
